Drawing for NEVIA

USPTO serial 99183535

NEVIA

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
WICKERSHAM, JUSTIN SPENCER
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with NEVIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brooks Lindsay

Brooks Lindsay Light Legal PLLC7103 55th Ave SSeattle, WA 98118United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable mobile application software for providing and optimizing neuromodulation therapy for gut health; Downloadable computer software using artificial intelligence (AI) technology for managing gastrointestinal and inflammatory conditions through transcutaneous cervical vagus nerve stimulation (tcVNS) and transcutaneous auricular vagus nerve stimulation (taVNS); Downloadable computer software for providing and tracking brain-gut axis treatment sessions, providing personalized gut health recommendations, monitoring progress, and interfacing with wearable medical devicesACTIVEMay 5, 2025
010Non-invasive wearable gut-health medical devices for therapeutic neuromodulation, namely, devices that apply simultaneous transcutaneous cervical vagus nerve stimulation (tcVNS) and transcutaneous auricular vagus nerve stimulation (taVNS) for the treatment of inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Crohn's Disease, and ulcerative colitis; Medical apparatuses, namely, biofeedback sensors using artificial intelligence (AI) technology featuring dual-modality vagus nerve stimulation for modulating immune function and reducing gut inflammationACTIVEMay 5, 2025
042Providing online non-downloadable software using artificial intelligence (AI) technology for managing gastrointestinal and inflammatory conditions through transcutaneous cervical vagus nerve stimulation (tcVNS) and transcutaneous auricular vagus nerve stimulation (taVNS); Providing online non-downloadable software for providing and tracking braingut axis treatment sessions, providing personalized gut health recommendations, monitoring progress, and interfacing with wearable medical devicesACTIVE—
044Providing online digital medical services in the field of gastroenterology, namely, personalized therapeutic support in the nature of remote monitoring for inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) delivered through guided neuromodulation therapy using artificial intelligence (AI) technology for medical diagnosis and treatment purposes; Medical consultation and monitoring services for individuals with gut conditions using transcutaneous cervical and auricular vagus nerve stimulation delivered via wearable devices and mobile applications; Healthcare services, namely, gut-health treatment featuring the integration of bioelectronic therapy, symptom tracking, and real-time treatment adjustment to support immune modulation and inflammation reductionACTIVEMay 5, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 28, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 27, 2026EX1GSOU EXTENSION 1 GRANTED—
Jul 27, 2026EXT1SOU EXTENSION 1 FILED—
Jul 27, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 3, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 9, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 9, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 3, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 6, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 5, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 5, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 5, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 30, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2025DOCKASSIGNED TO EXAMINER—
Sep 23, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 13, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
May 13, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance